Barclays Maintains Overweight on IFF, PT Down to $78 from $84
ByAinvest
Friday, Aug 8, 2025 9:38 am ET1min read
BCS--
IFF has been making strategic acquisitions to expand its product offerings and market reach. On July 1, 2025, the company announced the acquisition of Dave Barry Plastics, a move aimed at enhancing its presence in the life sciences sector [2]. Additionally, IFF acquired Termomeccanica Industrial Compressors S.p.A. for approximately €160 million, further bolstering its industrial portfolio [3].
Despite these strategic moves, IFF's second-quarter 2025 earnings saw a drop in adjusted earnings but an increase in revenue. The company reported adjusted earnings per share (EPS) of $0.80, matching FactSet estimates, while revenue rose to $1.89 billion, exceeding the $1.85 billion forecast [4]. IFF has also revised its full-year 2025 revenue guidance upward, reflecting robust industrial demand [5].
Barclays' price target adjustment comes as other financial institutions have also recently revised their targets for IFF. Citigroup lowered its target to $94 from $104, while Goldman Sachs raised its target to $108 from $101 [6, 7]. These adjustments highlight the varied opinions among analysts regarding IFF's stock valuation.
IFF's stock has been subject to various price target adjustments by different financial institutions, with analysts expressing mixed ratings. UBS Group, Oppenheimer, Robert W. Baird, Mizuho, Morgan Stanley, and Barclays have all issued recent reports, with varying price targets and ratings [8].
Investors should note that IFF's stock has seen significant fluctuations in recent months. The stock traded down $5.02 on Wednesday, hitting $65.60, following UBS Group's target price reduction [8]. Despite the recent price drop, IFF has a 12-month low of $63.71 and a 12-month high of $106.77, indicating a wide range of price movements [8].
IFF's insiders have also been active in the stock market. EVP Stephen N. Landsman acquired 12,000 shares of the stock in May, while Director Kevin O'byrne bought 4,500 shares [9]. These insider purchases suggest confidence in the company's long-term prospects.
In conclusion, Barclays' adjustment of its price target on IFF reflects the mixed opinions among analysts regarding the stock's valuation. The recent acquisitions and earnings reports highlight IFF's strategic moves and market position. Investors should carefully consider the varied opinions and recent developments when evaluating IFF's stock.
References:
[1] https://www.marketscreener.com/news/barclays-adjusts-price-target-on-international-flavors-fragrances-to-78-from-84-maintains-overw-ce7c5edfdf8df12d
[2] https://www.marketscreener.com/news/ingersoll-rand-acquires-dave-barry-plastics-09-13am-mt-07-01-2025
[3] https://www.marketscreener.com/news/ingersoll-rand-acquires-termomeccanica-industrial-compressors-07-02-2025
[4] https://www.marketscreener.com/news/earnings-flash-ir-ingersoll-rand-inc-reports-q2-revenue-1-89b-vs-factset-est-of-1-85b-07-31-2025
[5] https://www.marketscreener.com/news/ingersoll-rand-revises-revenue-guidance-for-the-full-year-2025-07-31-2025
[6] https://www.marketscreener.com/news/citigroup-adjusts-price-target-on-ingersoll-rand-to-94-from-104-maintains-buy-rating-06-43am-mt-07-01-2025
[7] https://www.marketscreener.com/news/goldman-sachs-adjusts-price-target-on-ingersoll-rand-to-104-from-108-maintains-buy-rating-06-43am-mt-07-01-2025
[8] https://www.marketbeat.com/instant-alerts/international-flavors-fragrances-nyseiff-price-target-cut-to-7900-by-analysts-at-ubs-group-2025-08-06/
[9] https://www.marketscreener.com/news/insider-trading-activity-at-international-flavors-fragrances-07-31-2025
C--
DAVE--
FDS--
FISI--
Barclays Maintains Overweight on IFF, PT Down to $78 from $84
Barclays has adjusted its price target on International Flavors & Fragrances (IFF), lowering it from $84 to $78 while maintaining an "overweight" rating on the stock. The change comes amidst a series of recent developments, including IFF's acquisitions and earnings reports.IFF has been making strategic acquisitions to expand its product offerings and market reach. On July 1, 2025, the company announced the acquisition of Dave Barry Plastics, a move aimed at enhancing its presence in the life sciences sector [2]. Additionally, IFF acquired Termomeccanica Industrial Compressors S.p.A. for approximately €160 million, further bolstering its industrial portfolio [3].
Despite these strategic moves, IFF's second-quarter 2025 earnings saw a drop in adjusted earnings but an increase in revenue. The company reported adjusted earnings per share (EPS) of $0.80, matching FactSet estimates, while revenue rose to $1.89 billion, exceeding the $1.85 billion forecast [4]. IFF has also revised its full-year 2025 revenue guidance upward, reflecting robust industrial demand [5].
Barclays' price target adjustment comes as other financial institutions have also recently revised their targets for IFF. Citigroup lowered its target to $94 from $104, while Goldman Sachs raised its target to $108 from $101 [6, 7]. These adjustments highlight the varied opinions among analysts regarding IFF's stock valuation.
IFF's stock has been subject to various price target adjustments by different financial institutions, with analysts expressing mixed ratings. UBS Group, Oppenheimer, Robert W. Baird, Mizuho, Morgan Stanley, and Barclays have all issued recent reports, with varying price targets and ratings [8].
Investors should note that IFF's stock has seen significant fluctuations in recent months. The stock traded down $5.02 on Wednesday, hitting $65.60, following UBS Group's target price reduction [8]. Despite the recent price drop, IFF has a 12-month low of $63.71 and a 12-month high of $106.77, indicating a wide range of price movements [8].
IFF's insiders have also been active in the stock market. EVP Stephen N. Landsman acquired 12,000 shares of the stock in May, while Director Kevin O'byrne bought 4,500 shares [9]. These insider purchases suggest confidence in the company's long-term prospects.
In conclusion, Barclays' adjustment of its price target on IFF reflects the mixed opinions among analysts regarding the stock's valuation. The recent acquisitions and earnings reports highlight IFF's strategic moves and market position. Investors should carefully consider the varied opinions and recent developments when evaluating IFF's stock.
References:
[1] https://www.marketscreener.com/news/barclays-adjusts-price-target-on-international-flavors-fragrances-to-78-from-84-maintains-overw-ce7c5edfdf8df12d
[2] https://www.marketscreener.com/news/ingersoll-rand-acquires-dave-barry-plastics-09-13am-mt-07-01-2025
[3] https://www.marketscreener.com/news/ingersoll-rand-acquires-termomeccanica-industrial-compressors-07-02-2025
[4] https://www.marketscreener.com/news/earnings-flash-ir-ingersoll-rand-inc-reports-q2-revenue-1-89b-vs-factset-est-of-1-85b-07-31-2025
[5] https://www.marketscreener.com/news/ingersoll-rand-revises-revenue-guidance-for-the-full-year-2025-07-31-2025
[6] https://www.marketscreener.com/news/citigroup-adjusts-price-target-on-ingersoll-rand-to-94-from-104-maintains-buy-rating-06-43am-mt-07-01-2025
[7] https://www.marketscreener.com/news/goldman-sachs-adjusts-price-target-on-ingersoll-rand-to-104-from-108-maintains-buy-rating-06-43am-mt-07-01-2025
[8] https://www.marketbeat.com/instant-alerts/international-flavors-fragrances-nyseiff-price-target-cut-to-7900-by-analysts-at-ubs-group-2025-08-06/
[9] https://www.marketscreener.com/news/insider-trading-activity-at-international-flavors-fragrances-07-31-2025

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet